for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BioNTech SE - ADR

22UAy.DE

Latest Trade

255.60EUR

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

65.50

 - 

395.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
255.60
Open
--
Volume
--
3M AVG Volume
88.84
Today's High
--
Today's Low
--
52 Week High
395.00
52 Week Low
65.50
Shares Out (MIL)
241.52
Market Cap (MIL)
67,502.17
Forward P/E
6.83
Dividend (Yield %)
--

Next Event

Q3 2021 BioNTech SE Earnings Release

Latest Developments

More

EMA Starts Evaluating Use Of COVID-19 Vaccine Comirnaty In Children Aged 5 To 11

Pfizer And Biontech Submit Data To EMA For Vaccination Of Children 5 To <12 Years Of Age With Comirnaty

Pfizer Says Co And Biontech Officially Submitted Request To FDA For Authorization Of COVID-19 Vaccine In Children 5 To <12 - Tweet

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About BioNTech SE - ADR

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Industry

Biotechnology & Drugs

Contact Info

An der Goldgrube 12

55131

Germany

+49.6131.90840

https://biontech.de/

Key Stats

2.69 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2019

0.1K

2020

0.5K

2021(E)

16.7K
EPS (EUR)

2019

-0.850

2020

0.060

2021(E)

34.889
Price To Earnings (TTM)
14.62
Price To Sales (TTM)
7.46
Price To Book (MRQ)
10.53
Price To Cash Flow (TTM)
14.06
Total Debt To Equity (MRQ)
21.87
LT Debt To Equity (MRQ)
8.87
Return on Investment (TTM)
120.65
Return on Equity (TTM)
80.46

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up